Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC
Conditions: Bowen's Disease; Cutaneous Squamous Cell Carcinoma in Situ Intervention: Drug: STP705 Sponsors: Sirnaomics; Amarex Clinical Research Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials